First PTAB Grant of Attorneys' Fees Awarded to Wolf Greenfield Client RPX
The USPTO’s Patent Trial and Appeal Board has rarely sanctioned a party in a post-grant proceeding, and never previously awarded attorneys’ fees as a sanction. That changed on July 1, when the Board granted a motion for attorneys’ fees filed by Wolf Greenfield client RPX Corp.
Check Out Our Recent Post-Grant Success
Wolf Greenfield's Post-Grant Proceedings Group went 8 for 8 on IPR institutions in July, and 7 for 7 in June. Read more and subscribe to our post-grant blog.
USPTO Provides Updates to Patent Subject Matter Eligibility Guidance
Dan Young and Jessica Colantonio explain the USPTO's recently issued updates to its patent subject matter eligibility guidance.
New York Times Quotes Oona Johnstone on Biosimilar Patents
Oona Johnstone was quoted by The New York Times in an article titled "Makers of Humira and Enbrel Using New Drug Patents to Delay Generic Versions."
Functional Claiming at the PTAB: A Lose-Lose Situation?
Brandon Blackwell explains a recent IPR that showed how functional claiming can play out at the PTAB.
Board Lets Some of the Air Out of Purge Valve Patent
You received this email because you are subscribed to Wolf Greenfield Emails from Wolf, Greenfield & Sacks, P.C.. If you prefer not to receive emails from Wolf, Greenfield & Sacks, P.C. you may unsubscribe or set your email preferences.
